Click a link below to view the mailing archive as if it had been sent to you.
| 2020-06-30 12:15 | | U.S. FDA to release guidance on COVID-19 vaccine approval and more... |
| 2020-06-30 00:15 | | Roche Gets FDA OK for Injectable Version of Breast Cancer Drug and more... |
| 2020-06-29 12:15 | | Gilead's long-awaited remdesivir price is $3,120, in line with watchdog estimates and more... |
| 2020-06-29 00:15 | | In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys and more... |
| 2020-06-28 00:15 | | J&J scraps late-stage study testing Stelara for lupus and more... |
| 2020-06-27 00:15 | | WHO, global partners launch $18B COVID-19 vaccine initiative and more... |
| 2020-06-26 12:15 | | Allergan ex-CEO Saunders takes board seat at BridgeBio and more... |
| 2020-06-26 00:15 | | Novartis inks settlements worth $347M with DOJ, SEC over foreign doctor payments, records keeping and more... |
| 2020-06-25 12:15 | | Vaccine alliance finds manufacturing capacity for 4 billion doses of coronavirus vaccines and more... |
| 2020-06-25 00:15 | | Bayer Settles Roundup Lawsuit for Almost $11 Billion and more... |
| 2020-06-24 12:15 | | AstraZeneca first to join FDA's push for patient-reported symptoms in cancer trials and more... |
| 2020-06-24 00:15 | | 6 pharmaceutical, devicemaker bankruptcies in 2020 and more... |
| 2020-06-23 12:15 | | Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's and more... |
| 2020-06-23 00:15 | | Gilead to Test Inhaled Form of Remdesivir in COVID-19 Starting in August and more... |
| 2020-06-22 12:15 | | Roche, BioNTech post 'low' response rate in cancer vaccine trial and more... |
| 2020-06-22 00:15 | | How Moderna's Second Worst Nightmare Could Become a Reality and more... |
| 2020-06-21 00:15 | | A Wearable That Has the Potential to Detect COVID-19 and more... |
| 2020-06-20 00:15 | | Pfizer's blockbuster-to-be Vyndaqel is too costly for heart patients, study suggests |
| 2020-06-19 12:15 | | Here’s why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies’ biotech-research team and more... |
| 2020-06-19 00:15 | | Roche's Checkpoint Inhibitor Hits the Mark in Early Triple-Negative Breast Cancer Study and more... |
| 2020-06-18 12:15 | | AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy and more... |
| 2020-06-18 00:15 | | A new hope for Amarin? Vascepa generic settlement leaves analysts split on patent appeal success and more... |
| 2020-06-17 12:15 | | Merck eats the lunch Bristol Myers never served, winning TMB-based OK for Keytruda and more... |
| 2020-06-17 00:15 | | Exec Search Underway at PacBio After CEO, CFO Announce Plans to Retire and more... |
| 2020-06-16 12:15 | | Researchers: ‘Major Breakthrough’ Drug Reduces Coronavirus Deaths By One-Third and more... |
| 2020-06-16 00:15 | | FDA Revokes Emergency Use Authorization for Hydroxychloroquine and Chloroquine as COVID-19 Treatments and more... |
| 2020-06-15 12:15 | | No Signature Required: FDA Provides Temporary Relief from Obligation to Obtain Physical Signatures for Prescription Drug Samples and more... |
| 2020-06-15 00:15 | | Could Gilead Sciences Have an HIV Cure Waiting in the Wings? and more... |
| 2020-06-14 00:15 | | Could This Recent IPO Biotech Become the Next Moderna? and more... |
| 2020-06-13 00:15 | | FDA approves Gardasil 9, the HPV vaccine, to prevent head-and-neck cancer and more... |
| 2020-06-12 12:15 | | New CRISPR, gene therapy results strengthen potential for treatment of blood diseases and more... |
| 2020-06-12 00:15 | | One of biotech’s biggest conferences grapples with how to talk about race and identity and more... |
| 2020-06-11 12:15 | | Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes and more... |
| 2020-06-11 00:15 | | Pharma sales rep salary survey finds annual incomes rising, but COVID concerns mounting and more... |
| 2020-06-10 12:15 | | AbbVie to pay Genmab $750M upfront to form bispecific R&D pact and more... |
| 2020-06-10 00:15 | | How Covid-19 is accelerating adoption of decentralized clinical trials and more... |
| 2020-06-09 12:15 | | Evox’s exosome platform draws Lilly in potential $1.2B CNS deal and more... |
| 2020-06-09 00:15 | | CSL Behring Buys Vitaeris, Picks Up Transplant Rejection Therapeutic and more... |
| 2020-06-08 12:15 | | Oxford Biomedica snags manufacturing equipment to ramp up production of COVID-19 vaccine and more... |
| 2020-06-08 00:15 | | AstraZeneca Approaches Gilead About Potential Merger and more... |
| 2020-06-07 00:15 | | AstraZeneca’s Calquence Showed Improvement In Small Group Of Hospitalized Covid-19 Patients and more... |
| 2020-06-05 12:15 | | Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech's biggest IPO of 2020 and more... |
| 2020-06-05 00:15 | | AstraZeneca reaches deals with health charities to supply coronavirus vaccine worldwide and more... |
| 2020-06-04 12:15 | | Europe mulls BARDA-style development contracts for COVID-19 vaccines: Bloomberg and more... |
| 2020-06-04 00:15 | | Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support and more... |
| 2020-06-03 12:15 | | COVID-19 Employment and Whistleblower Issues - Interview With an Employment Attorney and more... |
| 2020-06-03 00:15 | | BMS' Recently Approved MS Drug Shows Promise in Ulcerative Colitis Study and more... |
| 2020-06-02 12:15 | | Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis and more... |
| 2020-06-02 00:15 | | ASCO data for Amgen’s acute leukemia drug disappoint, but path forward remains, experts say and more... |
| 2020-06-01 12:15 | | Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action and more... |
| 2020-06-01 00:15 | | ASCO: Has AstraZeneca finally found a place for long-plagued I-O candidate tremelimumab? and more... |
